Glooko – Diabetes verfolgen
71
Quality Score
Strong
Glooko – Diabetes verfolgen
Medium confidence
✍️ bumetric analysis
“
Glooko – Diabetes verfolgen is an iOS app from Glooko, Inc. in the Medical category, currently rated 4.7★ across 8,970 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 71: Strong (healthy traction). For a Medical app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
→
12-mo forecast
$5.2K – $10.8K
per month
→
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$140K
↳ What it cost to build · not monthly revenue
Likely range $105K – $190K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (149 MB) | +$39K |
| ⚙ Medical complexity ×1.55 | +$49K |
Total estimate
$140K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$20K
↳ What it would sell for · not monthly revenue
Marketplace range $15K – $25K · 18× MRR multiple
💸
~0.1× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.4 (solid) | +8% |
| 🏷 Medical category multiple | +12% |
Final multiple
18× MRR
👥 Estimated audience size
490K
Lifetime downloads (US-equivalent)
Monthly active
120K
Daily active
24K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
DAU / MAU
20% sticky
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 46/100MID TIERunderperforming peersGrowth Velocity
5.0
Founder Strength
3.0
Product Quality
8.4
Revenue Strength
3.7
Monetization Maturity
1.0
Defensibility
4.5
Market Position
1.5
Operational Safety
10.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.65★ across 8,970 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 12 of 12 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Excellent rating (4.7★)METRIC | +$2,200 | |
| bugsREVIEW | −$1,800 | |
| 5 starREVIEW | +$1,800 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (8,970 ratings)METRIC | +$1,500 | |
| Mature app (14y old)METRIC | +$1,500 | |
| Multilingual (18 languages)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| too expensiveREVIEW | −$1,000 | |
| priceyREVIEW | −$800 | |
| Ad-supported / freemiumMETRIC | +$600 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v6.15.1
• CamAPS Liberty Usage Statistics: CamAPS users can now view statistics related to their use of Liberty mode.
• DiaExpert Account Integration: The option to connect to a DiaExpert account is now available.
• DiaExpert Account Integration: The option to connect to a DiaExpert account is now available.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Glooko – Diabetes verfolgen
- Developer
- Glooko, Inc.
- Bundle ID
- com.glooko.Logbook
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- 4+
- Languages
- AR, HR, CS, DA, NL, EN, FI, FR, DE, EL, IT, NB, PL, PT, SK, ES, SV, TR
Company
- Website
- Not found
- Tagline
- Diabetesversorgung neu gestalten
- Description
- Glooko verbindet Patienten, Fachpersonal und Geräte zur Vereinfachung der Versorgung, Optimierung von Arbeitsabläufen und Lieferung von messbaren Ergebnissen.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $1.0K/mo
- Top-grossing rank
- Outside top 100 in US Medical
- All-time revenue
- Not found
- Pricing
- Not found
Founder
- Name
- Not found
- X / Twitter
- twitter.com/glookoinc
- linkedin.com/company/glooko
- GitHub
- Not found
- X followers
- Not found
- Public statements
- Not found
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth8,970 ratings+14% lifetimeShow 3-year history estimate ▾
Tracked (54 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Glooko is a comprehensive diabetes management platform that helps people with diabetes quickly and easily understand and control their blood glucose levels and well-being. People with diabetes looking to take the next step with their diabetes management can track their blood glucose, insulin, weight, exercise, food, and medications in one place to make more informed decisions around their health.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 149 MB🔞 4+📱 iOS 16.0+🔖 v6.15.1🔄 updated 0d ago🌐 AR, HR, CS, DA, NL +13📂 Medical💰 Free
📅
What Worked™ · Development Pipeline
8 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
🔄
Monetization changed: freemium → free
2026-03
⭐
Rating ↑ 2.88 → 4.50 (improved 1.62★)
2026-03
📈
Crossed 500 ratings — social-proof flywheel kicking in
2015-01
📈
Crossed 100 ratings — social-proof flywheel kicking in
2013-03
📈
Crossed 50 ratings — social-proof flywheel kicking in
2012-01
📈
Crossed 10 ratings — social-proof flywheel kicking in
2011-11
⭐
Rating ↓ 5.00 → 4.33 (dropped 0.67★)
2011-11
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 5 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 4.415★ | 200 | 4.415★ this version |
| 🇨🇦 CA | 4.58565★ | 432 | 4.58565★ this version |
| 🇩🇪 DE | 4.50133★ | 1,506 | 4.50133★ this version |
| 🇬🇧 GB | 4.62404★ | 1,814 | 4.62404★ this version |
| 🇺🇸 US | 4.65115★ | 9,153 | 4.65115★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for Glooko – Diabetes verfolgen: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
About this analysis
Why medium confidence: 8,970 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Glooko – Diabetes verfolgen make per month?▴
Based on our ML-calibrated revenue forecast, Glooko – Diabetes verfolgen earns approximately $1.0K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Glooko – Diabetes verfolgen?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Glooko – Diabetes verfolgen?▴
Glooko – Diabetes verfolgen is published by Glooko, Inc. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Glooko – Diabetes verfolgen's BU Score?▴
Glooko – Diabetes verfolgen has a BU Score of 71/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.